The molecular landscape of the University of Michigan laryngeal squamous cell carcinoma cell line panel

Jacqueline E. Mann, Aditi Kulkarni, Andrew C. Birkeland, Judy Kafelghazal, Julia Eisenberg, Brittany M. Jewell, Megan L. Ludwig, Matthew E. Spector, Hui Jiang, Thomas E. Carey, J. Chad Brenner

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Background: Laryngeal squamous cell carcinomas (LSCCs) have a high risk of recurrence and poor prognosis. Patient-derived cancer cell lines remain important preclinical models for advancement of new therapeutic strategies, and comprehensive characterization of these models is vital in the precision medicine era. Methods: We performed exome and transcriptome sequencing as well as copy number analysis of a panel of LSCC-derived cell lines that were established at the University of Michigan and are used in laboratories worldwide. Results: We observed a complex array of alterations consistent with those reported in The Cancer Genome Atlas head and neck squamous cell carcinoma project, including aberrations in PIK3CA, EGFR, CDKN2A, TP53, and NOTCH family and FAT1 genes. A detailed analysis of FAT family genes and associated pathways showed disruptions to these genes in most cell lines. Conclusions: The molecular profiles we have generated indicate that as a whole, this panel recapitulates the molecular diversity observed in patients and will serve as useful guides in selecting cell lines for preclinical modeling.

Original languageEnglish (US)
Pages (from-to)3114-3124
Number of pages11
JournalHead and Neck
Volume41
Issue number9
DOIs
StatePublished - Jan 1 2019
Externally publishedYes

Fingerprint

Squamous Cell Carcinoma
Cell Line
Genes
Exome
Precision Medicine
Atlases
Transcriptome
Neoplasms
Genome
Recurrence
Therapeutics

Keywords

  • cell lines
  • exome sequencing
  • HNSCC
  • laryngeal cancer
  • precision medicine
  • UM-SCC

ASJC Scopus subject areas

  • Otorhinolaryngology

Cite this

Mann, J. E., Kulkarni, A., Birkeland, A. C., Kafelghazal, J., Eisenberg, J., Jewell, B. M., ... Brenner, J. C. (2019). The molecular landscape of the University of Michigan laryngeal squamous cell carcinoma cell line panel. Head and Neck, 41(9), 3114-3124. https://doi.org/10.1002/hed.25803

The molecular landscape of the University of Michigan laryngeal squamous cell carcinoma cell line panel. / Mann, Jacqueline E.; Kulkarni, Aditi; Birkeland, Andrew C.; Kafelghazal, Judy; Eisenberg, Julia; Jewell, Brittany M.; Ludwig, Megan L.; Spector, Matthew E.; Jiang, Hui; Carey, Thomas E.; Brenner, J. Chad.

In: Head and Neck, Vol. 41, No. 9, 01.01.2019, p. 3114-3124.

Research output: Contribution to journalArticle

Mann, JE, Kulkarni, A, Birkeland, AC, Kafelghazal, J, Eisenberg, J, Jewell, BM, Ludwig, ML, Spector, ME, Jiang, H, Carey, TE & Brenner, JC 2019, 'The molecular landscape of the University of Michigan laryngeal squamous cell carcinoma cell line panel', Head and Neck, vol. 41, no. 9, pp. 3114-3124. https://doi.org/10.1002/hed.25803
Mann, Jacqueline E. ; Kulkarni, Aditi ; Birkeland, Andrew C. ; Kafelghazal, Judy ; Eisenberg, Julia ; Jewell, Brittany M. ; Ludwig, Megan L. ; Spector, Matthew E. ; Jiang, Hui ; Carey, Thomas E. ; Brenner, J. Chad. / The molecular landscape of the University of Michigan laryngeal squamous cell carcinoma cell line panel. In: Head and Neck. 2019 ; Vol. 41, No. 9. pp. 3114-3124.
@article{9b1b3b3aa4224e7d9348324d3901e53f,
title = "The molecular landscape of the University of Michigan laryngeal squamous cell carcinoma cell line panel",
abstract = "Background: Laryngeal squamous cell carcinomas (LSCCs) have a high risk of recurrence and poor prognosis. Patient-derived cancer cell lines remain important preclinical models for advancement of new therapeutic strategies, and comprehensive characterization of these models is vital in the precision medicine era. Methods: We performed exome and transcriptome sequencing as well as copy number analysis of a panel of LSCC-derived cell lines that were established at the University of Michigan and are used in laboratories worldwide. Results: We observed a complex array of alterations consistent with those reported in The Cancer Genome Atlas head and neck squamous cell carcinoma project, including aberrations in PIK3CA, EGFR, CDKN2A, TP53, and NOTCH family and FAT1 genes. A detailed analysis of FAT family genes and associated pathways showed disruptions to these genes in most cell lines. Conclusions: The molecular profiles we have generated indicate that as a whole, this panel recapitulates the molecular diversity observed in patients and will serve as useful guides in selecting cell lines for preclinical modeling.",
keywords = "cell lines, exome sequencing, HNSCC, laryngeal cancer, precision medicine, UM-SCC",
author = "Mann, {Jacqueline E.} and Aditi Kulkarni and Birkeland, {Andrew C.} and Judy Kafelghazal and Julia Eisenberg and Jewell, {Brittany M.} and Ludwig, {Megan L.} and Spector, {Matthew E.} and Hui Jiang and Carey, {Thomas E.} and Brenner, {J. Chad}",
year = "2019",
month = "1",
day = "1",
doi = "10.1002/hed.25803",
language = "English (US)",
volume = "41",
pages = "3114--3124",
journal = "Head and Neck Surgery",
issn = "0148-6403",
publisher = "Wiley-Liss Inc.",
number = "9",

}

TY - JOUR

T1 - The molecular landscape of the University of Michigan laryngeal squamous cell carcinoma cell line panel

AU - Mann, Jacqueline E.

AU - Kulkarni, Aditi

AU - Birkeland, Andrew C.

AU - Kafelghazal, Judy

AU - Eisenberg, Julia

AU - Jewell, Brittany M.

AU - Ludwig, Megan L.

AU - Spector, Matthew E.

AU - Jiang, Hui

AU - Carey, Thomas E.

AU - Brenner, J. Chad

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Background: Laryngeal squamous cell carcinomas (LSCCs) have a high risk of recurrence and poor prognosis. Patient-derived cancer cell lines remain important preclinical models for advancement of new therapeutic strategies, and comprehensive characterization of these models is vital in the precision medicine era. Methods: We performed exome and transcriptome sequencing as well as copy number analysis of a panel of LSCC-derived cell lines that were established at the University of Michigan and are used in laboratories worldwide. Results: We observed a complex array of alterations consistent with those reported in The Cancer Genome Atlas head and neck squamous cell carcinoma project, including aberrations in PIK3CA, EGFR, CDKN2A, TP53, and NOTCH family and FAT1 genes. A detailed analysis of FAT family genes and associated pathways showed disruptions to these genes in most cell lines. Conclusions: The molecular profiles we have generated indicate that as a whole, this panel recapitulates the molecular diversity observed in patients and will serve as useful guides in selecting cell lines for preclinical modeling.

AB - Background: Laryngeal squamous cell carcinomas (LSCCs) have a high risk of recurrence and poor prognosis. Patient-derived cancer cell lines remain important preclinical models for advancement of new therapeutic strategies, and comprehensive characterization of these models is vital in the precision medicine era. Methods: We performed exome and transcriptome sequencing as well as copy number analysis of a panel of LSCC-derived cell lines that were established at the University of Michigan and are used in laboratories worldwide. Results: We observed a complex array of alterations consistent with those reported in The Cancer Genome Atlas head and neck squamous cell carcinoma project, including aberrations in PIK3CA, EGFR, CDKN2A, TP53, and NOTCH family and FAT1 genes. A detailed analysis of FAT family genes and associated pathways showed disruptions to these genes in most cell lines. Conclusions: The molecular profiles we have generated indicate that as a whole, this panel recapitulates the molecular diversity observed in patients and will serve as useful guides in selecting cell lines for preclinical modeling.

KW - cell lines

KW - exome sequencing

KW - HNSCC

KW - laryngeal cancer

KW - precision medicine

KW - UM-SCC

UR - http://www.scopus.com/inward/record.url?scp=85065962038&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85065962038&partnerID=8YFLogxK

U2 - 10.1002/hed.25803

DO - 10.1002/hed.25803

M3 - Article

C2 - 31090975

AN - SCOPUS:85065962038

VL - 41

SP - 3114

EP - 3124

JO - Head and Neck Surgery

JF - Head and Neck Surgery

SN - 0148-6403

IS - 9

ER -